特应性皮炎中移动健康与数字生物标志物的研究进展

doi:10.35541/cjd.20260061

Abstract

Abstract: 【Abstract】 With the development of mobile health technologies, digital biomarkers have gradually emerged as a promising focus in disease monitoring and management. Unlike conventional biomarkers obtained through clinical examinations or laboratory testing, digital biomarkers are primarily derived from real-world settings and enable continuous, dynamic data collection. Atopic dermatitis （AD） is a common chronic inflammatory skin disease characterized by recurrent flares and fluctuating disease activity, often requiring frequent medical intervention. In this context, integrating digital biomarkers into AD management is critical for enabling long-term monitoring of the disease and facilitating the development of personalized intervention strategies. This review provides a systematic review of recent advances in mobile health technologies and digital biomarkers in AD, highlighting the current applications and potential of smartphone- and wearable device-based approaches for the prevention, monitoring, remote management, and personalized treatment of AD.

Key words: Dermatitis, atopic, Biomarkers, mHealth, Wearable devices, Artificial intelligence

Ge Jiayi, Liu Yixuan, Zhou Yuan, Yao Xu. Mobile health and digital biomarkers in atopic dermatitis[J]. Chinese Journal of Dermatology, 2026, 59(6): 571-577.doi:10.35541/cjd.20260061

References ［62］

［1］	Silverberg JI, Mohawk JA, Cirulli J, et al. Burden of disease and unmet needs in atopic dermatitis: results from a patient survey［J］. Dermatitis, 2023,34（2）:135⁃144. DOI: 10.1089/derm.2022. 29015.jsi.
［2］	Macias Alonso AK, Hirt J, Woelfle T, et al. Definitions of digital biomarkers: a systematic mapping of the biomedical literature［J］. BMJ Health Care Inform, 2024,31（1）:e100914. DOI: 10. 1136/bmjhci⁃2023⁃100914.
［3］	Epstein E, Patel N, Maysent K, et al. Cardiac rehab in the COVID era and beyond: mHealth and other novel opportunities［J］. Curr Cardiol Rep, 2021,23（5）:42. DOI: 10.1007/s11886⁃021⁃01482⁃7.
［4］	Liu CX, Li L, Zeng YP. The role of air pollution in the pathogenesis of atopic dermatitis, with a focus on oxidative stress［J］. Clin Transl Allergy, 2025,15（9）:e70104. DOI: 10.1002/clt2.70104.
［5］	Atzeni M, Cossu L, Gaiotti S, et al. AirPredict: an eHealth platform for asthma management leveraging wearable sensors, digital diaries, and air quality monitoring to optimize patient outcomes［J］. Front Digit Health, 2025,7:1573342. DOI: 10. 3389/fdgth.2025.1573342.
［6］	Piquero⁃Casals J, Carrascosa JM, Morgado⁃Carrasco D, et al. The role of photoprotection in optimizing the treatment of atopic dermatitis［J］. Dermatol Ther （Heidelb）, 2021,11（2）:315⁃325. DOI: 10.1007/s13555⁃021⁃00495⁃y.
［7］	Huang X, Chalmers AN. Review of wearable and portable sensors for monitoring personal solar UV exposure［J］. Ann Biomed Eng, 2021,49（3）:964⁃978. DOI: 10.1007/s10439⁃020⁃02710⁃x.
［8］	Schmid⁃Grendelmeier P, Gooderham MJ, Hartmann K, et al. Efficacy and safety of abrocitinib in patients with moderate⁃to⁃severe atopic dermatitis and comorbid allergies［J］. Allergy, 2024,79（1）:174⁃183. DOI: 10.1111/all.15952.
［9］	Torisu⁃Itakura H, Anderson P, Piercy J, et al. Impact of itch and skin pain on quality of life in adult patients with atopic dermatitis in Japan: results from a real⁃world, point⁃in⁃time, survey of physicians and patients［J］. Curr Med Res Opin, 2022,38（8）:1401⁃1410. DOI: 10.1080/03007995.2022.2092352.
［10］	Erickson S, Kim BS. Research techniques made simple: itch measurement in clinical trials［J］. J Invest Dermatol, 2019,139（2）:264⁃269. DOI: 10.1016/j.jid.2018.12.004.
［11］	Gelhorn H, Currie BM, Bushnell DM, et al. Psychometric validation of the Worst Itch Numerical Rating Scale （WI⁃NRS） and other patient⁃reported outcome measures for assessing severity and impact of pruritus in patients with primary biliary cholangitis［J］. Orphanet J Rare Dis, 2025,20（1）:390. DOI: 10.1186/s13023⁃025⁃03798⁃x.
［12］	Yang AF, Nguyen M, Li AW, et al. Use of technology for the objective evaluation of scratching behavior: a systematic review［J］. JAAD Int, 2021,5:19⁃32. DOI: 10.1016/j.jdin.2021.06.005.
［13］	Ebata T, Iwasaki S, Kamide R, et al. Use of a wrist activity monitor for the measurement of nocturnal scratching in patients with atopic dermatitis［J］. Br J Dermatol, 2001,144（2）:305⁃309. DOI: 10.1046/j.1365⁃2133.2001.04019.x.
［14］	Hon KL, Lam MC, Leung TF, et al. Nocturnal wrist movements are correlated with objective clinical scores and plasma chemokine levels in children with atopic dermatitis［J］. Br J Dermatol, 2006,154（4）:629⁃635. DOI: 10.1111/j.1365⁃2133. 2006.07213.x.
［15］	Smith MP, Ly K, Thibodeaux Q, et al. Emerging methods to objectively assess pruritus in atopic dermatitis［J］. Dermatol Ther （Heidelb）, 2019,9（3）:407⁃420. DOI: 10.1007/s13555⁃019⁃0312⁃3.
［16］	Feuerstein J, Austin D, Sack R, et al. Wrist actigraphy for scratch detection in the presence of confounding activities［J］. Annu Int Conf IEEE Eng Med Biol Soc, 2011,2011:3652⁃3655. DOI: 10.1109/IEMBS.2011.6090615.
［17］	Petersen J, Austin D, Sack R, et al. Actigraphy⁃based scratch detection using logistic regression［J］. IEEE J Biomed Health Inform, 2013,17（2）:277⁃283. DOI: 10.1109/TITB.2012.2204761.
［18］	Moreau A, Anderer P, Ross M, et al. Detection of nocturnal scratching movements in patients with atopic dermatitis using accelerometers and recurrent neural networks［J］. IEEE J Biomed Health Inform, 2018,22（4）:1011⁃1018. DOI: 10.1109/JBHI.2017.2710798.
［19］	Mahadevan N, Christakis Y, Di J, et al. Development of digital measures for nighttime scratch and sleep using wrist⁃worn wearable devices［J］. NPJ Digit Med, 2021,4（1）:42. DOI: 10. 1038/s41746⁃021⁃00402⁃x.
［20］	Ji J, Venderley J, Zhang H, et al. Assessing nocturnal scratch with actigraphy in atopic dermatitis patients［J］. NPJ Digit Med, 2023,6（1）:72. DOI: 10.1038/s41746⁃023⁃00821⁃y.
［21］	Chun KS, Kang YJ, Lee JY, et al. A skin⁃conformable wireless sensor to objectively quantify symptoms of pruritus［J］. Sci Adv, 2021,7（18）:eabf9405. DOI: 10.1126/sciadv.abf9405.
［22］	Noro Y, Omoto Y, Umeda K, et al. Novel acoustic evaluation system for scratching behavior in itching dermatitis: rapid and accurate analysis for nocturnal scratching of atopic dermatitis patients［J］. J Dermatol, 2014,41（3）:233⁃238. DOI: 10.1111/1346⁃8138.12405.
［23］	Okuyama T, Otsuki M, Komiya R, et al. A curvature sensor using a solid polymer electrolyte［J］. Int J Appl Electromagn Mech, 2010,33（1⁃2）:823⁃829. DOI: 10.3233/JAE⁃2010⁃1191.
［24］	Liu Y, Zhang G, Tarolli CG, et al. Monitoring gait at home with radio waves in Parkinson′s disease: a marker of severity, progression, and medication response［J］. Sci Transl Med, 2022,14（663）:eadc9669. DOI: 10.1126/scitranslmed.adc9669.
［25］	Avey S, Morris M, Sargsyan D, et al. At⁃home evaluation of both wearable and touchless digital health technologies for measuring nocturnal scratching in atopic dermatitis: analytical validation study［J］. J Med Internet Res, 2025,27:e72216. DOI: 10.2196/72216.
［26］	Toyota S, Kogure T, Kondo E, et al. Scratch scoring by a sheet⁃shaped body vibrometer in nocturnal sleep: a pilot study compared with infrared video recording［J］. Acta Derm Venereol, 2025,105:adv41414. DOI: 10.2340/actadv.v105.41414.
［27］	Ikoma A, Ebata T, Chantalat L, et al. Measurement of nocturnal scratching in patients with pruritus using a smartwatch: initial clinical studies with the itch tracker app［J］. Acta Derm Venereol, 2019,99（3）:268⁃273. DOI: 10.2340/00015555⁃3105.
［28］	Sugiyama A, Murakami Y, Okamoto K, et al. Nocturnal scratching and quality of sleep in children with atopic dermatitis［J］. Acta Derm Venereol, 2023,103:adv12345. DOI: 10.2340/actadv.v103.12345.
［29］	Khan Y, Todorov A, Torah R, et al. Skin sensing and wearable technology as tools to measure atopic dermatitis severity［J］. Skin Health Dis, 2024,4（5）:e449. DOI: 10.1002/ski2.449.
［30］	Jeong HK, Park C, Henao R, et al. Deep learning in dermatology: a systematic review of current approaches, outcomes, and limitations［J］. JID Innov, 2023,3（1）:100150. DOI: 10.1016/j.xjidi.2022.100150.
［31］	Wu H, Yin H, Chen H, et al. A deep learning, image based approach for automated diagnosis for inflammatory skin diseases［J］. Ann Transl Med, 2020,8（9）:581. DOI: 10.21037/atm.2020. 04.39.
［32］	Pan K, Hurault G, Arulkumaran K, et al. EczemaNet: automating detection and severity assessment of atopic dermatitis［C］//Liu M, Yan P, Lian C, et al. Machine learning in medical imaging. Cham:Springer, 2020:220⁃230. DOI:10.1007/978⁃3⁃030⁃59861⁃7_23.
［33］	Medela A, Mac Carthy T, Aguilar Robles SA, et al. Automatic scoring of atopic dermatitis using deep learning: a pilot study［J］. JID Innov, 2022,2（3）:100107. DOI: 10.1016/j.xjidi.2022.100107.
［34］	Choi Y, Oh SJ, Lee JH. Novel technology at hand to measure skin hydration by Biodisplay smartphone touch screen panel［J］. Sci Rep, 2021,11（1）:19410. DOI: 10.1038/s41598⁃021⁃98784⁃1.
［35］	Jang M, Kim HD, Koo HJ, et al. Textile⁃based wearable sensor for skin hydration monitoring［J］. Sensors （Basel）, 2022,22（18）:6985. DOI: 10.3390/s22186985.
［36］	Krishnan SR, Su CJ, Xie Z, et al. Wireless, battery⁃free epidermal electronics for continuous, quantitative, multimodal thermal characterization of skin［J］. Small, 2018,14（47）:e1803192. DOI: 10.1002/smll.201803192.
［37］	Sim D, Kim SM, Kim SS, et al. Portable skin analyzers with simultaneous measurements of transepidermal water loss, skin conductance and skin hardness［J］. Sensors （Basel）, 2019,19（18）:3857. DOI: 10.3390/s19183857.
［38］	Westermann T, Viana VR, Berto Junior C, et al. Measurement of skin hydration with a portable device （SkinUp® Beauty Device） and comparison with the Corneometer®［J］. Skin Res Technol, 2020,26（4）:571⁃576. DOI: 10.1111/srt.12833.
［39］	Fluhr JW, Voisard A, Nikolaeva DG, et al. Stratum corneum hydration measurements with a bluetooth wireless probe: a real⁃life study at home compared to measurements under laboratory conditions［J］. Skin Pharmacol Physiol, 2024,37（1⁃3）:40⁃48. DOI: 10.1159/000539411.
［40］	Tobar M, Clemann S, Hagens R, et al. Skinly: a novel handheld IoT device for validating biophysical skin characteristics［J］. Skin Res Technol, 2024,30（3）:e13613. DOI: 10.1111/srt.13613.
［41］	Berdyshev E, Goleva E, Bissonnette R, et al. Dupilumab significantly improves skin barrier function in patients with moderate⁃to⁃severe atopic dermatitis［J］. Allergy, 2022,77（11）:3388⁃3397. DOI: 10.1111/all.15432.
［42］	Grinich EE, Topham C, Haynes D, et al. Validation of a novel patient⁃operated device for measuring skin barrier function in atopic dermatitis［J］. Skin Res Technol, 2021,27（5）:824⁃830. DOI: 10.1111/srt.13027.
［43］	Logger J, Driessen R, de Jong E, et al. Value of GPSkin for the measurement of skin barrier impairment and for monitoring of rosacea treatment in daily practice［J］. Skin Res Technol, 2021,27（1）:15⁃23. DOI: 10.1111/srt.12900.
［44］	Sivakumar AD, Sharma R, Thota C, et al. WASP: wearable analytical skin probe for dynamic monitoring of transepidermal water loss［J］. ACS Sens, 2023,8（11）:4407⁃4416. DOI: 10.1021/acssensors.3c01936.
［45］	Hong I, Lim D, Kim D, et al. Breathable, wearable skin analyzer for reliable long⁃term monitoring of skin barrier function and individual environmental health impacts［J］. Nat Commun, 2025,16（1）:9149. DOI: 10.1038/s41467⁃025⁃64207⁃2.
［46］	Lin PH, Nien HH, Li BR. Wearable microfluidics for continuous assay［J］. Annu Rev Anal Chem （Palo Alto Calif）, 2023,16（1）:181⁃203. DOI: 10.1146/annurev⁃anchem⁃091322⁃082930.
［47］	Szegedi K, Lutter R, Res PC, et al. Cytokine profiles in interstitial fluid from chronic atopic dermatitis skin［J］. J Eur Acad Dermatol Venereol, 2015,29（11）:2136⁃2144. DOI: 10. 1111/jdv.13160.
［48］	Xu J, Yang B, Kong J, et al. Real⁃time monitoring and early warning of a cytokine storm in vivo using a wearable noninvasive skin microneedle patch［J］. Adv Healthc Mater, 2023,12（18）:e2203133. DOI: 10.1002/adhm.202203133.
［49］	Salfi F, Amicucci G, Ferrara M, et al. The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patients［J］. Arch Dermatol Res, 2023,315（6）:1577⁃1582. DOI: 10.1007/s00403⁃023⁃02538⁃0.
［50］	Lee J, Suh H, Jung H, et al. Association between chronic pruritus, depression, and insomnia: a cross⁃sectional study［J］. JAAD Int, 2021,3:54⁃60. DOI: 10.1016/j.jdin.2021.02.004.
［51］	Menne F, Dörr F, Schräder J, et al. The voice of depression: speech features as biomarkers for major depressive disorder［J］. BMC Psychiatry, 2024,24（1）:794. DOI: 10.1186/s12888⁃024⁃06253⁃6.
［52］	Kim AY, Jang EH, Lee SH, et al. Automatic depression detection using smartphone⁃based text⁃dependent speech signals: deep convolutional neural network approach［J］. J Med Internet Res, 2023,25:e34474. DOI: 10.2196/34474.
［53］	Di Matteo D, Wang W, Fotinos K, et al. Smartphone⁃detected ambient speech and self⁃reported measures of anxiety and depression: exploratory observational study［J］. JMIR Form Res, 2021,5（1）:e22723. DOI: 10.2196/22723.
［54］	Tian J, Cao Y, Li Y, et al. A sympathetic⁃eosinophil axis orchestrates psychological stress to exacerbate skin inflammation［J］. Science, 2026,391（6791）:1269⁃1277. DOI: 10.1126/science. adv5974.
［55］	Cherrez⁃Ojeda I, Robles⁃Velasco K, Osorio MF, et al. A systematic review and meta⁃analysis of mobile health applications and telemonitoring in atopic dermatitis self⁃management［J］. Dermatol Ther （Heidelb）, 2024,14（7）:1787⁃1798. DOI: 10.1007/s13555⁃024⁃01213⁃0.
［56］	Santer M, Muller I, Becque T, et al. Eczema Care Online behavioural interventions to support self⁃care for children and young people: two independent, pragmatic, randomised controlled trials［J］. BMJ, 2022,379:e072007. DOI: 10.1136/bmj⁃2022⁃072007.
［57］	Cerqueira TB, Imoto RR, Muzzolon M, et al. WhatsApp and atopic dermatitis: a clinical trial［J］. J Pediatr （Rio J）, 2025,101（1）:67⁃73. DOI: 10.1016/j.jped.2024.07.003.
［58］	Zvulunov A, Lenevich S, Migacheva N. Mobile health app as an auxiliary tool in management of atopic dermatitis in children: randomized controlled trial［J］. JMIR Dermatol, 2025,8:e60479. DOI: 10.2196/60479.
［59］	Nelson CA, Pérez⁃Chada LM, Creadore A, et al. Patient perspectives on the use of artificial intelligence for skin cancer screening: a qualitative study［J］. JAMA Dermatol, 2020,156（5）:501⁃512. DOI: 10.1001/jamadermatol.2019.5014.
［60］	Sulejmani P, Negris O, Aoki V, et al. The global reach of artificial intelligence in atopic dermatitis: the quality and reliability of ChatGPT responses in 8 languages［J］. JAAD Int, 2024,17:158⁃159. DOI: 10.1016/j.jdin.2024.08.013.
［61］	Yang AF, Patel S, Chun KS, et al. Artificial intelligence⁃enabled wearable devices and nocturnal scratching in mild atopic dermatitis［J］. JAMA Dermatol, 2025,161（4）:406⁃410. DOI: 10.1001/jamadermatol.2024.5697.
［62］	Zarif A. The ethical challenges facing the widespread adoption of digital healthcare technology［J］. Health Technol （Berl）, 2022,12（1）:175⁃179. DOI: 10.1007/s12553⁃021⁃00596⁃w.

[1]	Lei Liangxinwen, Wu Hao, Lu Zhong. Application of optical coherence tomography in cosmetic dermatology [J]. Chinese Journal of Dermatology, 2026, 59(3): 273-277.
[2]	Wang Juncheng, Liu Jie. Artificial intelligence in psoriasis: diagnosis, treatment and patient management [J]. Chinese Journal of Dermatology, 2026, 0(3): 20240061-e20240061.
[3]	Ma Tongchuan, Cai Xinying, Wang Rui, Dong Liping, Chen Lele, Xiao Fengli, . Serum lipidomic profiling in patients with dermatomyositis based on ultra-performance liquid chromatography-mass spectrometry [J]. Chinese Journal of Dermatology, 2025, 58(8): 736-743.
[4]	Lu Qianjin, Cao Shumei, Jiang Jiao. Lupus erythematosus research: current status and challenges [J]. Chinese Journal of Dermatology, 2025, 58(8): 715-728.
[5]	Song Zhiqiang, Yang Xianjie, Chen Qiquan. Disease management and modification in chronic spontaneous urticaria: needs and prospects in the new era [J]. Chinese Journal of Dermatology, 2025, 58(6): 503-507.
[6]	Ye Mingyu, Shi Yanting, Li Hao, Xiang Jie, Wang Song, Cao Hua. Clinical significance of serum galectin-9 levels in the evaluation of combined tumors in dermatomyositis patients [J]. Chinese Journal of Dermatology, 2025, 58(4): 328-333.
[7]	Dong Yi, Yan Xin, Munire·Tayier, Zhang Xingqi. Application of machine learning in dermatology [J]. Chinese Journal of Dermatology, 2025, 0(3): 20240290-e20240290.
[8]	Yu Jin, Li Ruoyu. Diagnosis and treatment of cutaneous fungal infections: current status, challenges, and perspectives [J]. Chinese Journal of Dermatology, 2025, 58(12): 1130-1133.
[9]	Chen Zhu, Dong Liping, Xiao Fengli, . Research progress in atopic diseases from the perspective of metabolomics [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220366-e20220366.
[10]	Wang Yukun, Liu Jie. Application of deep learning in non-neoplastic dermatoses [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220660-e20220660.
[11]	Pan Ruoxin, Gu Duoduo, Zhang Yue, Li Min, Tao Meng, Xu Yang. Metabolomics in rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 178-181.
[12]	Yang Yongting, Li Tingting, Kang Xiaojing. Biomarkers related to the treatment of melanoma with immune checkpoint inhibitors [J]. Chinese Journal of Dermatology, 2023, 56(3): 278-283.
[13]	He Qing, Zhang Tao, Wang Xiuli, Gao Xinghua, Chen Hongduo, Liu Min, Qi Ruiqun. Biomarkers associated with malignant progression of actinic keratosis [J]. Chinese Journal of Dermatology, 2023, 0(2): 20220284-e20220284.
[14]	Zhu Yajie, Lu Feng, Syed Mohammad Nooruddin Mahmood, Liu Xin, Li Xiaohong, Yu Jianbin, Dong Huiting. Evaluation of the performance of a 34-layer ResNet model-based artificial intelligence application, in the diagnosis of skin diseases [J]. Chinese Journal of Dermatology, 2023, 56(10): 948-952.
[15]	Tian Jing, Liang Yuan, Shen Chunping, Zhao Mutong, Wang Yang, Wang Shan, Jiao Lei, Ma Lin. Analysis of short-term efficacy and safety of the first subcutaneous injection of dupilumab in the treatment of moderate-to-severe childhood atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 299-303.

Mobile health and digital biomarkers in atopic dermatitis

PDF

Knowledge

Abstract

Cite this article

share this article

References ［62］

Related Articles 15

Metrics

Comments

Recommended 0